The impact of ACT-funded research
Medical research in a clinical setting is essential if patient care and treatment is to be further improved. ACT provides significant support for clinical research and between 2007 and 2013 granted 117 research awards (totalling £2,707,547) which supported more than 200 researchers at Addenbrooke’s and the Rosie hospitals and the University of Cambridge. Evaluating the impact of this funding is important and in 2013 ACT commissioned an independent report which showed:
- ACT research awards are of high strategic value, investing in people and adding value to extend CUH research capabilities. The research provided patients with opportunities to participate in research
- About half of the funding was allocated to cancer research and the remainder to reproductive and child health, oral and gastro-intestinal, cardiovascular, stroke, mental health and neurology research
- There were high value successes, with some immediate patient benefits resulting from changes to hospital policy and guidelines, staff training, and exerting influence in the East Anglia region and beyond. Ninety five original research publications (acknowledging ACT alongside other funders) fuelled the public domain with new knowledge to facilitate the translation of research into future patient benefits.